Connect with us

Science

Cannabis can reduce liver damage caused by alcohol – study

Cannabinoids were shown to reduce toxicity in the liver caused by ethanol.

Published

on

Cannabinoids were shown to reduce some of the liver damage caused by excessive alcohol consumption. Photo by cottonbro studio.

Could cannabis help mitigate some of the liver damage caused by excessive alcohol consumption? A recent study suggests so.  

Cannabis is often touted as a less harmful alternative to alcohol, and now a new study has found that the compounds found in the plant may actually reduce some of the liver damage caused by excessive alcohol consumption.

According to the findings, cannabinoids were shown to reduce toxicity in the liver caused by ethanol – the chemical compound found in alcohol. 

The outcomes have led those behind the  study to conclude that they could even be a potential treatment for impaired liver function, also known as hepatotoxicity.

For the study, researchers investigated the protective effects of cannabinoids against ethanol (EtOH)-induced liver toxicity in rats.

The animals were divided into seven groups, all of which were treated with different combinations of ethanol and cannabinoids. 

READ MORE: Cannabis no more of a risk than tobacco and alcohol – study

An analysis revealed that the groups which were treated with higher doses of cannabinoids demonstrated a reduction in inflammation in comparison to the animals treated only with ethanol.

The authors note that levels of COX-2, CD-14, and MIP-2 inflammation markers showed a ‘remarkable decrease’ in the groups treated with cannabinoids, compared to control groups.

Further analysis showed that the cannabinoids acted as inhibitors to the mitogen-activated protein kinase pathways, which are involved in cellular responses to stimuli, such as mitogens, osmotic stress and proinflammatory cytokines.

The study concludes: “Our findings suggest that CB [cannabinoids] is a potential candidate for the treatment of alcohol-induced hepatotoxicity.”

Previous research 

Previous studies have investigated the potential of cannabinoids, particularly CBD as a therapeutic treatment for alcohol use disorder and alcohol-induced damage to the liver and brain.

One study from 2019 found that CBD not only reduced drinking in those with alcohol use disorder, but also reduced alcohol-related steatosis and fibrosis in the liver, ‘modulating inflammation’ and reducing oxidative stress.

Elsewhere, researchers from the University of Colorado at Boulder and Colorado State University explored the relationship between cannabis use and alcohol intake in people who were enrolled in an alcohol treatment programme.

The findings, published in the journal, Addiction, reported that on days when these participants consumed cannabis, their alcohol intake fell significantly. This trend was consistent among those who used heavy amounts of cannabis as well as among those who used only light amounts of cannabis occasionally.

Home » Science » Cannabis can reduce liver damage caused by alcohol – study

Sarah Sinclair is an award-winning freelance journalist covering health, drug policy and social affairs. She is one of the few UK reporters specialising in medical cannabis policy and as the former editor of Cannabis Health has covered developments in the European cannabis sector extensively, with a focus on patients and consumers. She continues to report on cannabis-related health and policy for Forbes, Cannabis Health and Business of Cannabis and has written for The i Paper, Byline Times, The Lead, Positive News, Leafie & others. Sarah has an NCTJ accreditation and an MA in Journalism from the University of Sunderland and has completed additional specialist training through the Medical Cannabis Clinicians Society in the UK. She has spoken at leading industry events such as Cannabis Europa.

Trending

Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.